Biological activities of antisera against synthetic oligopeptides were examined. The peptide antisera were directed against amino acids 6 to 12 (pepl), 124 to 131 (pep2), 256 to 262 (pep3), 283 to 290 (pep4) and 434 to 441 (pep5) of the viral envelope glycoprotein (gp70). Peptide-specific antisera did not neutralize viral infectivity. However, antibodies to pep4 and pep5, which bound to the hydrophobic part of gp70, mediated the complement-dependent lysis of Friend murine leukaemia virus (FLV)-infected cells. STU mice were immunized against FLV-induced erythroleukaemia with synthetic oligopeptides. Vaccines containing only one of these peptides (single-peptide vaccines) as well as multi-peptide vaccines containing pepl, -4, -5 or pepl, -2, -3, -4, -5 were used. Whereas the immunizations with single-peptide vaccines did not protect the immunized mice from FLV-induced erythroleukaemia, multi-peptide vaccines enhanced the survival rate and incubation period after FLV challenge. These results revealed that immunological reactions distinct from neutralizing antibodies can be evoked by immunization with synthetic peptides and can confer limited protection against FLV-induced erythroleukaemia.
INTRODUCTION
Progress in the analysis of primary structures of polypeptides and nucleic acids, and in the synthesis of oligopeptides, has made the use of synthetic peptides a new promising approach to vaccine development, Studies with monoclonal antibodies show that binding of antibodies to a single epitope may be sufficient to neutralize viral infectivity (Chesebro et al., 1981) . Consequently, it should be possible to use a single synthetic epitope as an effective vaccine. The idea of such a minimal vaccine is not new. G6bel (1939) reported a protective immunization against pneumococcal infection with a single disaccharide of the bacterial coat, and antisera against an oligopeptide of the coat protein of tobacco mosaic virus were shown to neutralize viral infectivity (Anderer & Schlumberger, 1965) . Recently, Bittle et al. (1982) reported the active immunization against foot-and-mouth disease virus with a synthetic oligopeptide representing 20 amino acids of the viral VP1 protein.
The practical importance of such synthetic vaccines is not yet clear. In numerous trials, peptide antibodies have been shown to react with viral polypeptides but the antisera were not able to neutralize viral infection (Sutcliffe et al., 1983) . In biochemical and immunological studies, however, synthetic peptides and their antisera are useful tools (Walter & Doolittle, 1983) .
We described earlier synthetic peptides and their use for structural and immunological characterization of the Friend murine leukaemia virus (FLV) glycoprotein gp70 (Bayer et aL, 1984) . These peptides had been selected according to the amino acid sequence of the gp70 (Koch et al., 1983) and corresponded to the amino acids 6 to 12 (pepl), 124 to 131 (pep2), 256 to 262 (pep3), 283 to 290 (pep4) and 434 to 441 (pep5). To choose the peptides, the amino acid sequence of the glycopolypeptide had been analysed and hydrophilicity, terminal position, predicted 0000-7320 O 1987 SGM reverse turns and type specificity were used as criteria for selection (Bayer et al., 1984) . Pepl and pep5 were terminal sequences of gp70. Pep2, pep3 and pep4 were hydrophilic. Pep2, pep3, pep4 and pep5 were type-specific for FLV, and pepl, pep2, pep4 and pep5 were predicted reverse turns. When compared with the gp52 of Friend spleen focus-forming virus (Wolff et al., 1983) pep1 had one of seven and pep4 had three of eight amino acids exchanged. Pep2, pep3 and pep5 were not detected on the gp52 sequence.
Pepl, pep2, pep4 and pep5 elicited antibodies to gp70 in rabbits. Moreover, pep3, pep4 and pep5 were found to be native epitopes of gp70 (Bayer et al., 1984) . Active immunization with isolated gp70 revealed that antibodies to gp70 effectively prevent FLV-induced erythroleukaemia (Hunsmann, 1985) . Antibodies to gp70 neutralize viral infectivity in vitro and induce lysis of FLV-infected cells by complement (Hunsmann et al., , 1976 . Furthermore, serum therapy of FLV-infected mice by antisera to gp70 demonstrated the importance of antibodies to the viral envelope for immunoprevention of FLV-induced erythroleukaemia (Schafer et al., 1976) .
Here we evaluated biological functions of antisera against the synthetic peptides of gp70. We showed that they do not neutralize viral infectivity, but do induce lysis of virus-infected cells. We have used synthetic peptides to actively immunize mice against FLV-induced erythroleukaemia. Vaccines containing several different peptides induced partial protection against the disease, while those containing only one of the peptides were not effective.
METHODS

Virus.
FLV (Friend, 1957) was isolated from spleens of infected mice. Each spleen, weighing about 2 g, was homogenized in 20 ml phosphate-buffered saline (PBS). Cell debris was removed by two steps of centrifugation, first at 250 g for 15 min, then at 4000 g for 30 min at 4 °C. The supernatant was filtered through a nitrocellulose filter with 200 nm pore size (Schleicher & Schiill) and stored in liquid nitrogen.
Cell cultures. FLV-producing Eveline cells (FES, Seifert et al., 1975) and uninfected mouse fibroblasts (NIH 3T3 cells) were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10~ heatinactivated foetal bovine serum (FBS). Fibroblasts were detached from the surface of the culture bottles by incubation with 1.25 g/l EDTA and 1.25 g/1 trypsin in PBS pH 7-2 for 5 rain at room temperature.
Purification of the viralglycopeptides. Gp70 was purified as described earlier (Bayer et al., 1984) by centrifugation from the culture supernatant of FES cells and by affinity chromatography using concanavalin A-Sepharose.
Micellar complexes (rosettes) consisting of the disulphide-linked viral envelope polypeptides gp70 and p15E were isolated after treatment of sedimented virus with 2,2'-dithiobis(5-nitropyridine) by sucrose density gradient centrifugation (Schneider et al., 1980) . Determination of specific antibodies in immune sera. Specific antibodies in mouse and rabbit sera were determined by an indirect ELISA (Bayer et al., 1984) . Synthetic peptides and viral glycopolypeptides were used as antigens. Antibodies binding to the antigens were detected by peroxidase-conjugated second antibodies. When antisera were tested only at a dilution of 1:100, those sera that exceeded the twofold values of preimmune sera were designated as weakly positive (+ ; antibody titres between 100 and 500). Those that exceeded the threefold values of preimmune sera were strongly positive (+) with antibody titres up to 12500
Infection and neutralization tests. STU mice (22 to 26 weeks old) (Sch/ifer, 1979) were injected intraperitoneally with 500 XC p.f.u. (Rowe et al., 1970) of FLV in 0.2 ml DMEM. To neutralize viral infectivity, complementinactivated antisera (56 °C, 30 rain) were added to the challenge virus and kept for 2 h at 16 °C before infection. Seven weeks later, the animals were sacrificed and the weights of their spleens were determined as a measure of the progression of the erythroleukaemia. Infected animals showed spleen weights of about 2 g while uninfected mice had spleens weighing about 0.1 g.
Assay for complement-mediated, antibody-induced cytotoxicity. Complement-mediated lysis of FLV-producing cells was determined by modifications of the techniques described by Hunsmann et al. (1976) and Sun & Lohmann-Matthes (1982) . Briefly, 106 cells in 0.4 ml DMEM supplemented with 10~ FBS were radioactively labelled with 0.15 mCi sodium chromate (51Cr; Amersham Buchler) for 1 h at 37 °C. Cells were washed twice with 5 ml DMEM by centrifugation for 5 min at 1000g and 2.5 × 104 cells corresponding to 1.2 x 104 c.p.m, in 0.1 ml DMEM were incubated with 0.1 ml antiserum for 45 rain at 37 °C using 96-well microtitre plates (Costar). Thereafter, cells were washed three times with 0.2 ml DMEM and incubated a second time for 15 min in 0-1 ml of a goat antiserum to rabbit immunoglobulins diluted 1 : 60 in DMEM. The cells were washed again three times and were incubated for 1 h at 37 °C with rabbit complement (Behring, Marburg, F.R.G.) diluted 1:6 in DMEM. The reaction was stopped by addition of 0.1 ml ice-cold DMEM. Cells were sedimented and the radioactivity in 0.1 ml supernatant was determined in a gamma-scintillation BF-5300 counter (Berthold, Wildbad, F.R.G.). The c.p.m. measured were corrected for spontaneous release of 5~Cr obtained with the preimmune sera. The amount of radioactivity released from the cells by three cycles of freezing and thawing was scored as 100~ 51Cr release.
Immunization and virus challenge. STU mice (8 to 12 weeks old) were immunized with synthetic peptides conjugated to keyhole limpet haemocyanin (KLH) by glutaraldehyde (Bayer et al., 1984) , Antigen solutions were emulsified with equal volumes of incomplete Freund's adjuvant and 0.2 ml was injected subcutaneously and intraperitoneally. Three immunizations at 3-week intervals using a total amount of 0.1 mg antigen were performed. The challenge virus was injected 2 weeks after the last immunization with a pre-titrated dose of 1500 XC p.f.c, of FLV.
Antisera. Rabbit antisera to the viral gp70, to the synthetic peptides (Bayer et al., I984) and to the FLV core polypeptide p30 (Hunsmann et at., 198l) were used. The goat serum against rabbit immunoglobulins was kindly provided by Professor W. Sch~ifer (Tfibingen, F.R.G.).
RESULTS
Peptide antibodies could not neutralize viral infectivity but they induced complement lysis of virus-
infected cells Peptide antisera raised in rabbits were used to examine the biological functions of the peptide antibodies (Bayer et al., 1984) . The influence of these antibodies on viral infectivity was examined in STU mice. Five-hundred XC p.f.u, of FLV in 0.1 ml PBS were incubated with 0.1 ml of the peptide antisera before inoculation of mice. Five weeks later, the animals were sacrificed and their spleens were weighed. The gp70 antiserum prevented splenomegaly, whereas the peptide antisera, preimmune sera, or antisera to calf serum and KLH were not effective (data not shown).
We next examined the activity of the peptide antisera to mediate complement-dependent lysis of FLV-infected cells. FLV-infected FES cells were labelled with 5 ~ Cr and the peptide antisera or control sera were examined for their ability to induce complement lysis. Only antisera to pep4 and pep5 were effective (Fig. 1) . The strongest activities were observed with those antisera that had high antibody titres to gp70 in the ELISA test (Bayer et al., 1984) . One of the pep5 antisera (with a gp70 antibody titre of 1035) induced as much 51Cr release as did the gp70 antiserum. No cytotoxicity of the peptide antisera was observed against uninfected fibroblasts (data not shown). 
Synthetic vaccines against FL V 519
Synthetic peptides were immunogenic and able to elicit gp70-reactive antibodies in mice Adult STU mice were immunized with synthetic peptides conjugated to KLH, with untreated KLH, or with viral glycoprotein complexes (gp85 rosettes; Schneider et al., 1980) . Serum samples were taken before immunization (preimmune sera) on day 62 before FLV challenge, after immunization (immune sera) on day 2 before FLV challenge, and 31 days after challenge with FLV. All mice immunized with gp85 developed antibodies to gp70 (Table 1 ). In the KLH control group, antibodies to gp70 were not observed after immunization, although one animal was positive after virus challenge.
After immunization of mice with the synthetic peptides, specific antibodies were detectable in all groups (Table 1) . Pepl, pep4 and pep5 were combined (pepl,4,5) in a vaccine because they effectively elicit gp70-reactive antisera in rabbits (Bayer et al., 1984) . Pepl was less immunogenic than pep2, pep3, pep4 and pep5, because only nine of 21 mice that had been immunized with pepl-containing vaccines developed pepl-specific antibodies,whereas all 10 mice immunized with pep2, all five mice immunized with pep3, all 20 mice immunized with pep4 and 17 of 20 mice immunized with pep5 had antibodies to the corresponding peptide.
The strongest reactivities to gp70 were obtained in mice treated with combinations of the synthetic peptides. In the single-peptide groups, pep2 and pep5 were also effective, whereas pepl and pep4 induced gp70-reactive peptide antibodies infrequently. Antibody levels in general did not rise after challenge.
Following immunization with synthetic peptides, 21 mice developed antibodies to synthetic peptides but not to gp70, whereas 15 animals developed gp70 antibodies as well.
Multi-peptide vaccines but not single-peptide vaccines increase survival time
After immunization, mice were infected with 1500 p.f.u, of FLV. Erythroleukaemia, splenomegaly and death resulted about 2 to 3 months later. As expected from our earlier results (Hunsmann et al., 1981) , immunization with gp85 complexes effectively prevented erythroleukaemia (Fig. 2) . The animal that died had an atypically small spleen weighing 1 g. Five of six KLH-immunized mice died by 110 days after challenge.
Immunization with the synthetic peptides was less effective than with gp85. No significant differences were observed between the KLH group and the single-peptide groups, but in the multi-peptide groups survival times after FLV challenge were enhanced, although clearly not as well as with gp85. DISCUSSION We used in vivo and in vitro studies to evaluate the biological functions of antibodies against synthetic oligopeptides selected from the amino acid sequence of the gp70 of FLV.
Antibodies induced in rabbits bound to the corresponding peptides, but did not neutralize viral infectivity. This was surprising because pep4 and pep5 are native epitopes of the glycoprotein (Bayer et al., 1984) .
Nevertheless, peptide antisera could induce complement-dependent lysis of virus-infected cells. Interestingly, only antibodies against pep4 and pep5, which map on the carboxy terminal half of gp70, were cytotoxic. This region is rich in hydrophobic amino acids. It is therefore assumed to mediate the binding of the gp70 to the integral membrane polypeptide (p15E) and the viral envelope. Because some of the complement compounds, e.g. C3b and C4, have short half-lives, antibodies binding to epitopes near the membrane may be more susceptible to complement, as observed with the high cytotoxic activity of antibodies to the hydrophobic envelope polypeptide pl5E (Hunsmann et al., 1976; Oroszlan & Nowinski, 1980) . The synthetic peptides also elicited antibodies to the native gp70. Compared to the results obtained in rabbits, pep1 and pep4 were less immunogenic in STU mice. It is possible that the peptides were related to those of endogenous retroviruses against which STU mice may be tolerant, because there is only one amino acid exchanged in the epitopes corresponding to pep 1 and pep4 in the endogenous leukaemia virus of AKR mice (Lenz et al., 1982) .
Of 32 peptide-specific mouse sera, only 15 reacted with gp70; therefore, the presence of peptide-specific antibodies was not sufficient for an antiserum to react with the native antigen. Thus, even in sequential determinants the conformation of the oligopeptide is important for antigenicity (Tainer et al.~ 1984) . In future synthetic vaccines the oligopeptides should therefore be fixed in conformation. After virus challenge, titres of gp70 antibodies increased drastically only in the pepl-KLH group. Similar priming by immunization with synthetic peptides has been reported after immunization against poliovirus or foot-and-mouth disease virus using synthetic vaccines (Emini et al., 1983; Francis et al., 1985) .
Immunizations with synthetic peptides were clearly less effective than those with gp85. Gp70-reactive antibodies induced by immunization with pepl, pep2, pep4 or pep5 did not influence survival time or survival frequency of mice (Fig. 2) . Immunization with combination vaccines (e.g. pepl,4,5-KLH and pept,2,3,4,5-KLH) produced long-term survival in seven of eight animals that developed gp70-reactive antibodies although four of five animals without gp70 reactivity died as fast as the KLH controls. Thus, prolongation of survival time was restricted to the animals that developed gp70 antibodies after immunization with multi-peptide vaccines (P < 0.01). The effect of immunization with the synthetic peptides was most likely restricted to interaction with the helper component of the FLV complex, since none of the peptide sequences was on the gp52 of spleen focus-forming virus.
The mechanism of protection is not clear, but antibodies to gp70 play the decisive role. As demonstrated by the experiments in vitro, peptide antibodies induced in rabbits that did not neutralize viral infectivity could still induce secondary immunological reactions in vivo (e.g. complement activation or antibody-mediated cellular cytotoxicity). In the FLV system, peptide antibodies could not prevent leukaemia effectively. In other retrovirus infections, however, for example with feline leukaemia virus, cytotoxic antibodies play an important role in remission of the disease (Liu et al., 1984) , and peptide vaccines may be more effective.
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